Cookie policy: This site uses cookies (small files stored on your computer) to simplify and improve your experience of this website. Cookies are small text files stored on the device you are using to access this website. For more information please take a look at our terms and conditions. Some parts of the site may not work properly if you choose not to accept cookies.

Join

Subscribe or Register

Existing user? Login

Respiratory tract diseases

Aspirin users see slower progression of emphysema

Aspirin reduces platelet activation and might be beneficial in diseases involving the pulmonary vasculature such as emphysema. In the image, micrograph of red blood cell platelets

Source: PHOTOTAKE Inc. / Alamy

Aspirin’s effects on platelet activation may slow the progression of emphysema, say researchers

Aspirin reduces platelet activation and may be beneficial in diseases involving the pulmonary vasculature. This hypothesis has gained new support from an analysis of the Multi-Ethnic Study of Atherosclerosis (MESA) Lung Study[1], which included 4,471 people aged 45–84 years.

When participants were stratified according to baseline aspirin use, those who used aspirin regularly had significantly slower progression of emphysema over ten years of follow-up compared with aspirin non-users. This held true after adjusting for multiple confounders and in propensity-score analyses. Similar reductions in emphysema progression were seen in ever-smokers while the greatest reductions were observed in individuals with airflow obstruction.

“Regular aspirin use may slow the progression of subclinical emphysema, perhaps through effects on platelet activation or inflammation,” says Carrie Aaron, one of the study’s authors, from the Columbia University Medical Center in New York.

Citation: The Pharmaceutical Journal DOI: 10.1211/PJ.2015.20068562

Have your say

For commenting, please login or register as a user and agree to our Community Guidelines. You will be re-directed back to this page where you will have the ability to comment.

Recommended from Pharmaceutical Press

RPS publications

Pharmaceutical Press is the publishing division of the Royal Pharmaceutical Society, and is a leading provider of authoritative pharmaceutical information used throughout the world.

Visit rpharms.com

Search an extensive range of the world’s most trusted resources

Powered by MedicinesComplete
  • Print
  • Share
  • Comment
  • Save
  • Print Friendly Version of this pagePrint Get a PDF version of this webpagePDF

Newsletter Sign-up

Want to keep up with the latest news, comment and CPD articles in pharmacy and science? Subscribe to our free alerts.